Bristol-Myers Squibb Company has had a recent 30% stock decline amid concerns over patent expirations. Click here to read why BMY stock is a Hold.

According to its SEC filing dated October 17, 2025, Shaker Investments sold all 10,774 shares of Salesforce during the third ...

Q3 2025 Management View CEO Rainer Blair emphasized strong third quarter results, driven by "DBS-driven execution paired with ...

Q1 2026 Management View Derek Schmidt, CEO, reported that Flexsteel delivered "6.2% sales growth in the quarter, which represents our eighth consecutive quarter of year-over-year growth," highlighting ...